Antiretroviral regimens for HIV and HBV co-infection in patients receiving rituximab
Lancet Haematol
.
2020 Dec;7(12):e857.
doi: 10.1016/S2352-3026(20)30325-2.
Author
Francisco J Rodríguez-Gómez
1
Affiliation
1
Unit of Infectious Diseases, Juan Ramón Jiménez Hospital, Huelva 21005, Spain. Electronic address: francisco.rodriguez.gomez.sspa@juntadeandalucia.es.
PMID:
33242440
DOI:
10.1016/S2352-3026(20)30325-2
No abstract available
Publication types
Letter
Comment
MeSH terms
Coinfection* / drug therapy
HIV Infections* / complications
HIV Infections* / drug therapy
Hematologic Neoplasms*
Hepatitis B virus
Humans
Patients
Rituximab / adverse effects
Substances
Rituximab